Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Ductal carcinoma in situ

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Remdesivir til behandling af COVID-19-pneumoni

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Varicocele Testis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Integration af specialiseret palliation og onkologi

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Akut luftvejsobstruktion grundet uerkendt akalasi efter ukompliceret vaginal fødsel

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Dansk Kvalitetsdatabase for Nyfødte (DKN) -resumé af årsrapport 2018. Indikator 9: antibiotikabehandling

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Dexamethasone Dose and Early Postoperative Recovery after Mastectomy: A Double-blind, Randomized Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Delayed two-stage breast reconstruction: The impact of radiotherapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Hvor bevæger forskningen i behandlingen af cancer sig hen?

    Research output: Contribution to journalJournal articleResearch

View graph of relations

Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.

Translated title of the contributionDuctal carcinoma in situ
Original languageDanish
JournalUgeskrift for Laeger
Volume180
Issue number38
ISSN0041-5782
Publication statusPublished - 17 Sep 2018

ID: 56652673